Table 2 Statistical data for tumor patient cohort.
N | MSI-H | MSS | |
|---|---|---|---|
N | 100 (100%) | 49 (49%) | 51 (51%) |
UICC stage | |||
II | 59 (59%) | 33 (33%) | 26 (26%) |
III | 41 (41%) | 16 (16%) | 25 (25%) |
T category | |||
T1 | 0 (0%) | 0 (0%) | 0 (0%) |
T2 | 4 (4%) | 1 (1%) | 3 (3%) |
T3 | 81 (81%) | 42 (42%) | 39 (39%) |
T4 | 15 (15%) | 6 (6%) | 9 (9%) |
N category | |||
N0 | 59 (59%) | 32 (32%) | 27 (27%) |
N1 | 21 (21%) | 7 (7%) | 14 (14%) |
N2 | 19 (19%) | 9 (9%) | 10 (10%) |
NX | 1 (1%) | 1 (1%) | 0 (0%) |
M category | |||
M0 | 100 (100%) | 49 (49%) | 51 (51%) |
sex | |||
male | 39 (39%) | 10 (10%) | 29 (29%) |
female | 61 (61%) | 39 (39%) | 22 (22%) |
localization | |||
Cecum (C18.0) | 20 (20%) | 13 (13%) | 7 (7%) |
acending colon (C18.2) | 26 (26%) | 18 (18%) | 8 (8%) |
right colonic flexure (C18.3) | 7 (7%) | 3 (3%) | 4 (4%) |
transverse colon(C18.4) | 11 (11%) | 7 (7%) | 4 (4%) |
left colonic flexure (C18.5) | 7 (7%) | 2 (2%) | 5 (5%) |
descending colon (C18.6) | 6 (6%) | 2 (2%) | 4 (4%) |
sigmoidic colon (C18.7) | 23 (23%) | 4 (4%) | 19 (19%) |
Median Age | 78 | 79 | 74 |
